| Patient | Mahatma Gandhi |
|---|---|
| Date of birth | 1955-10-02 |
| Identifiers | MRN HR-ET009-SYN; SSN (made up) 000-09-2246 |
| Document date | 2026-03-23 |
| Author | Arjun Malhotra, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week blood pressure review; planning for a fast next month; clinical nutrition consultation today. [S]
Mr. Gandhi returns four weeks after starting amlodipine 2.5 mg. He takes it each morning and has had no ankle swelling, flushing, or dizziness. He measures his own blood pressure twice a day; his home average is 148/86. He keeps his usual diet of goat's milk, curd, fruit, nuts, vegetables, and whole grains with little salt, and walks 5 km each morning. He tells us he intends to begin a seven-day fast of conscience in two weeks, taking only water with a little salt and citrus juice. He has thought about it carefully, understands the risks we described at the first visit, and asks for help to keep it as safely as possible. He had an echocardiogram and a bone density scan this morning and saw the dietitian. [S]
| Element | Detail |
|---|---|
| Medication tolerance | No ankle swelling, flushing, or dizziness on amlodipine 2.5 mg |
| Home blood pressure | Average 148/86 mmHg, twice-daily readings |
| Diet | Lacto-vegetarian with goat's milk and curd; little salt |
| Planned fast | Seven days from early April; water with a little salt and citrus juice only |
| Activity | Walks 5 km every morning |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No dizziness on standing, headache, or numbness |
| Constitutional | Negative | Weight steady; no fever |
| Gastrointestinal | Negative | Regular bowels; no sore tongue now |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 2.5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-23 to 2026-03-23 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily; hold on fast days and when standing blood pressure is below 110 systolic or he is dizzy on standing | One tablet by mouth daily, with hold rules | Oral route | 2026-03-23 | active | S |
| Vitamin B12 (cyanocobalamin) 1 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-23 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-23 | Body height | 165 | cm | S |
| 2026-03-23 | Body weight | 46.4 | kg | S |
| 2026-03-23 | Body mass index (BMI) [Ratio] | 17 | kg/m2 | S |
| 2026-03-23 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2026-03-23 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-03-23 | Heart rate | 62 | /min | S |
| 2026-03-23 | Respiratory rate | 14 | /min | S |
| 2026-03-23 | Body temperature | 36.5 | Cel | S |
| 2026-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-23 | DXA Lumbar spine [T-score] Bone density | -1.4 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 2026-03-23 | DXA Femur [T-score] Bone density | -2.2 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 2026-03-23 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 8.6 | % | S | ||
| 2026-03-23 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 2.6 | % | S | ||
| 2026-03-23 | Grip strength Hand - left Dynamometer | 22 | kg | S | ||
| 2026-03-23 | Grip strength Hand - right Dynamometer | 25 | kg | S |
Vital signs recorded on 2026-03-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin, alert, and good-humored |
| Orthostatic vital signs | Lying 148/86, standing at three minutes 144/84; no symptoms |
| Cardiovascular | Regular rhythm; no murmur or added sounds; no edema |
| Peripheral pulses | Pedal and posterior tibial pulses palpable on both sides |
| Neurological | Vibration sense present at the toes; Romberg negative |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Essential hypertension, stage 2, with mild concentric left ventricular hypertrophy; synthetic modern diagnosis linked to his documented high blood pressure | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by office and home readings; his high blood pressure is documented in his health file and his own letter (D). |
| Underweight (BMI 17.1) from a long-standing, chosen lean lacto-vegetarian diet and periodic fasting; at risk of malnutrition, with high refeeding risk after a fast | active | confirmed | R63.6 | S — Synthetic modern diagnosis; his documented weight of 46.7 kg at 5 feet 5 inches (D) gives a similar body mass index. |
| Vitamin B12 deficiency with raised methylmalonic acid and mild anemia, from a lacto-vegetarian diet | active | confirmed | E53.8 | S — Synthetic diagnosis from the baseline tests; his historical B12 status is not known. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic diagnosis from the baseline tests. |
| Low bone mass (osteopenia) by DXA, femoral neck T-score -2.2; FRAX below treatment thresholds | active | confirmed | M85.80 | S — Synthetic diagnosis; no bone density measure from his lifetime exists. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique | Every visit | Completed today | 146/84 mmHg, average of two seated readings |
| Self-management | Home blood pressure monitoring | At diagnosis and after each treatment change | Completed today | Home average 148/86 mmHg on amlodipine 2.5 mg |
| Examination | Orthostatic blood pressure | Every visit in an older adult on treatment | Completed today | No drop on standing |
| Examination | Weight and BMI | Every visit | Completed today | 46.4 kg, BMI 17.0 |
| Examination | Cardiac auscultation | Every visit | Completed today | Normal |
| Imaging | Echocardiogram | At diagnosis for stage 2 hypertension or suspected LVH | Completed today | Mild concentric left ventricular hypertrophy; ejection fraction 62% |
| Imaging | 12-lead ECG | Baseline | Up to date | Voltage criteria for left ventricular hypertrophy at intake |
| Examination | Peripheral pulses | Every 2 to 3 years at 65 or older | Completed today | Pedal pulses palpable |
| Laboratory | Metabolic panel, lipids, urine albumin-creatinine ratio, HbA1c, and TSH | Yearly; TSH at diagnosis | Up to date | All done at intake; normal |
| Examination | Fundoscopic examination | Yearly in chronic hypertension | Due | Not yet done; an eye examination is to be booked |
| Survey | PHQ-9 and 10-year cardiovascular risk | Yearly | Up to date | PHQ-9 score 3 at intake |
| Imaging | DXA of the spine and hip | Baseline in a man 70 or older or with low body weight; repeat every 2 years | Completed today | Lumbar spine T-score -1.4; femoral neck T-score -2.2 |
| Survey | FRAX 10-year fracture risk | With each DXA and when risk factors change | Completed today | Major osteoporotic fracture 8.6%; hip fracture 2.6% |
| Laboratory | Vitamin D, calcium, and secondary-cause tests for low bone mass | At diagnosis | Up to date | Calcium, phosphate, magnesium, creatinine, TSH, and blood count at intake; vitamin D low |
| Examination | Grip strength (nutrition-focused examination) | At nutrition assessment | Completed today | Left 22 kg, right 25 kg; below 27 kg |
| Referral | Registered dietitian consultation | Before a planned fast in a person at nutritional risk | Completed today | Seen today; nutrition plan and fast and refeeding plans agreed |
| Self-management | Fast safety plan agreed through shared decision-making | Before each planned fast | Completed today | Fluids, home readings, hold rules, daily calls, warning signs, and the post-fast visit agreed |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); Indian guidelines on hypertension-IV (2019) (2019); Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32) (2006, updated 2017); ASPEN Consensus Recommendations for Refeeding Syndrome (2020); The clinician's guide to prevention and treatment of osteoporosis (2022); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and osteoporosis monographs (2026)
Follow-up: Daily telephone check during the fast. Clinic visit the morning after the fast ends, before the first meal, with electrolytes. Next scheduled visit 2026-04-13: review the morning after a seven-day fast, before the first meal: refeeding risk assessment and start of refeeding. [S]